Juan Pablo Tartari
Overview
Explore the profile of Juan Pablo Tartari including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
245
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rosende-Roca M, Garcia-Gutierrez F, Cantero-Fortiz Y, Alegret M, Pytel V, Canabate P, et al.
Alzheimers Res Ther
. 2025 Jan;
17(1):27.
PMID: 39844303
Background: Alzheimer's disease (AD) stands as the leading cause of dementia worldwide, and projections estimate over 150 million patients by 2050. AD prevalence is notably higher in women, nearly twice...
2.
Alegret M, Blazquez-Folch J, Perez A, Ortega G, Espinosa A, Munoz N, et al.
J Clin Med
. 2024 Dec;
13(23).
PMID: 39685733
: Alzheimer's disease (AD) dementia and mild cognitive impairment (MCI) are currently underdiagnosed in the community, and early detection of cognitive deficits is crucial for timely intervention. FACEmemory, the first...
3.
Tonietto M, Sotolongo-Grau O, Roe-Vellve N, Bullich S, Tartari J, Sanabria A, et al.
Alzheimers Res Ther
. 2024 Nov;
16(1):257.
PMID: 39605030
Background: Second-generation tau tracers for positron emission tomography (PET) show high affinity for paired helical filaments tau deposits characteristic of Alzheimer´s disease and low off-target binding. Differences in their chemical...
4.
Castilla-Marti L, Garcia-Sanchez A, Martinez J, Rosende-Roca M, Vargas L, Tartari J, et al.
Alzheimers Res Ther
. 2024 Nov;
16(1):249.
PMID: 39550564
Background: Optical coherence tomography (OCT) enables high-resolution imaging of ocular structures in health and disease. Choroid thickness (CT) is a key vascular retinal parameter that can be assessed by OCT...
5.
Morato X, Tartari J, Pytel V, Boada M
J Alzheimers Dis
. 2024 Oct;
101(s1):S285-S298.
PMID: 39422946
Extracts made from plants are complex mixtures of substances with varying compositions depending on the plant material and method of manufacture. This complexity makes it difficult for scientists and clinicians...
6.
Cano A, Capdevila M, Puerta R, Arranz J, Montrreal L, de Rojas I, et al.
EBioMedicine
. 2024 Sep;
108:105345.
PMID: 39299003
Background: The identification of patients with an elevated risk of developing Alzheimer's disease (AD) dementia and eligible for the disease-modifying treatments (DMTs) in the earliest stages is one of the...
7.
Puerta R, de Rojas I, Garcia-Gonzalez P, Olive C, Sotolongo-Grau O, Garcia-Sanchez A, et al.
medRxiv
. 2024 Sep;
PMID: 39281766
Background: Alzheimer's disease (AD) has a high heritable component characteristic of complex diseases, yet many of the genetic risk factors remain unknown. We combined genome-wide association studies (GWAS) on amyloid...
8.
Garcia-Sanchez A, Sotolongo-Grau O, Tartari J, Sanabria A, Esteban-De Antonio E, Perez-Cordon A, et al.
Alzheimers Res Ther
. 2024 Feb;
16(1):42.
PMID: 38378643
Introduction: Optical coherence tomography angiography (OCT-A) is a novel tool that allows the detection of retinal vascular changes. We investigated the association of macular vessel density (VD) in the superficial...
9.
He R, Chapin K, Al-Tamimi J, Bel N, Marquie M, Rosende-Roca M, et al.
Am J Speech Lang Pathol
. 2023 Jul;
32(5):2075-2086.
PMID: 37486774
Background: Decline in language has emerged as a new potential biomarker for the early detection of Alzheimer's disease (AD). It remains unclear how sensitive language measures are across different tasks,...
10.
Morato X, Marquie M, Tartari J, Lafuente A, Abdelnour C, Alegret M, et al.
Sci Rep
. 2023 Apr;
13(1):5406.
PMID: 37012306
Although beta-amyloid (Aβ) and phosphorylated tau remain the preferred targets for disease-modifying treatments (DMT) against Alzheimer's disease (AD), part of the pathophysiological mechanisms of cognitive impairment are related to neuroinflammation...